Dr. Peter Marks, FDA's Director of the Center for Biologics Evaluation and Research, returns for his third episode to provide an update on COVID-19 vaccines and to discuss the upcoming Vaccines and Related Biological Products Advisory Committee meeting.

FDA Insight

Advisory Committee on COVID-19 Vaccines

Join FDA leaders as they provide their insight into issues facing the agency – including the COVID-19 pandemic and other emerging topics. The program will be on hiatus starting Jan. 20, 2021.

About

FDA Insight